5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC

Clinical trial NCT05317000 · RECRUITING

Trial details

NCT number: NCT05317000
Sponsor: Barbara Burtness
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of Head and Neck

Start date: 2023-03-23
Primary completion: 2028-06-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.